83 Result(s)

Article

Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial

We report the 12-year follow-up of the prospective randomized EBMT LYM1 trial to determine whether the benefit of brief duration rituximab maintenance (RM) on progression-free survival (PFS) in patients with r...

R. Pettengell, R. Uddin, A. Boumendil, R. Johnson… in Bone Marrow Transplantation (2021)

Article

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment option in advanced-stage mycosis fungoides (MF) and Sézary syndrome (SS). This study presents an updated analy...

E. Domingo-Domenech, R. F. Duarte, A. Boumedil, F. Onida… in Bone Marrow Transplantation (2021)

Article

Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT

Systemic anaplastic large cell lymphoma (sALCL) is a rare histological entity expressing the CD30 antigen that comprises around 11% of peripheral T-cell lymphoma. We analysed the outcome of patients with relap...

E. Domingo-Domènech, A. Boumendil, F. Climent, H. Sengeloev… in Bone Marrow Transplantation (2020)

Article

Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Information regarding the curative role of allogeneic stem cell transplantation (allo-HCT) in systemic anaplastic large cell lymphoma (sALCL) is scarce. We analyzed the results of allo-HCT in patients with rel...

E. Domingo-Domènech, A. Boumendil, F. Climent, G. Socié… in Bone Marrow Transplantation (2020)

Article

Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia

M. Fürstenau, J. Bahlo, A. M. Fink, E. Lange, P. Dreger, M. Dreyling, G. Hess… in Leukemia (2020)

Article

Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Autologous hematopoietic stem cell transplantation (auto-HSCT) is the standard of care for patients with diffuse large B-cell lymphoma (DLBCL) who relapse/progress after first line chemoimmunotherapy. Long-ter...

E. González-Barca, A. Boumendil, D. Blaise, M. Trněný… in Bone Marrow Transplantation (2020)

Article

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)

Preliminary data suggest that allogeneic stem cell transplantation (allo-SCT) may be effective in T-prolymphocytic leukemia (T-PLL). The purpose of the present observational study was to assess the outcome of ...

W. Wiktor-Jedrzejczak, J. Drozd-Sokolowska, D. J. Eikema… in Bone Marrow Transplantation (2019)

Article

Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD

There is increasing evidence that endothelial dysfunction is involved in refractoriness of acute GvHD (aGvHD). Here we investigated the hypothesis that another endothelial complication, transplant-associated t...

M Zeisbrich, N Becker, A Benner, A Radujkovic, K Schmitt… in Bone Marrow Transplantation (2017)

Article

Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party

Relapse remains the most common cause of treatment failure in patients receiving autologous stem cell transplantation (ASCT) for follicular lymphoma (FL). The aim of this study was to evaluate the effect of ad...

L Bento, A Boumendil, H Finel, S Le Gouill, S Amorim… in Bone Marrow Transplantation (2017)

Article

Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience

J Meissner, H Finel, S Dietrich, A Boumendil, E Kanfer… in Bone Marrow Transplantation (2017)

Article

GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses

Allogeneic stem cell transplantation (alloSCT) is used for treating patients with T-prolymphocytic leukemia (T-PLL). However, direct evidence of GvL activity in T-PLL is lacking. We correlated minimal residual...

L Sellner, M Brüggemann, M Schlitt, H Knecht, D Herrmann… in Bone Marrow Transplantation (2017)

Article

Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation

For young patients with high-risk CLL, BTK-/PI3K-inhibitors or allogeneic stem cell transplantation (alloHCT) are considered. Patients with a low risk of non-relapse mortality (NRM) but a high risk of failure ...

J Schetelig, L C de Wreede, M van Gelder, N S Andersen… in Bone Marrow Transplantation (2017)

Article

Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation

Even with the availability of targeted drugs, allogeneic hematopoietic cell transplantation (allo-HCT) is the only therapy with curative potential for patients with CLL. Cure can be assessed by comparing long-...

M van Gelder, L C de Wreede, M Bornhäuser, D Niederwieser… in Bone Marrow Transplantation (2017)

Article

Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)

Hematopoietic stem cell transplantation (HSCT) is used with increasing frequency in Europe with 40 000 transplants reported in 2014. Transplant-related mortality remains high in allogeneic HSCT (10–20%); high-...

J R Passweg, H Baldomero, P Bader, C Bonini, S Cesaro… in Bone Marrow Transplantation (2017)

Article

Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantation

S Dietrich, H Finel, C Martinez, J Tischer, D Blaise, P Chevallier, L Castagna… in Leukemia (2016)

Article

Transplantation in CLL: what we can learn from a dinosaur

P Dreger, E Montserrat in Bone Marrow Transplantation (2016)